kw.\*:("Gatifloxacino")
Results 1 to 25 of 246
Selection :
Fluorescence Determination of DNA Using the Gatifloxacin― Europium(III) ComplexLIPING WANG; CHANGCHUAN GUO; BO FU et al.Journal of agricultural and food chemistry (Print). 2011, Vol 59, Num 5, pp 1607-1611, issn 0021-8561, 5 p.Article
Determination of gatifloxacin in bulk and tablet preparations by high-performance liquid chromatographySALGADO, Hérida R. N; LOPES, Cristiani C. G. O.Journal of AOAC International. 2006, Vol 89, Num 3, pp 642-645, issn 1060-3271, 4 p.Article
Pharmacokinetics of gatifloxacin: dosing considerations and use in special populationsGRASELA, Dennis M; SCHEIFE, Richard T.Pharmacotherapy. 2000, Vol 20, Num 6, issn 0277-0008, 50 p., 2Serial Issue
Glucose homeostasis abnormalities associated with use of gatifloxacinFROTHINGHAM, Richard.Clinical infectious diseases. 2005, Vol 41, Num 9, pp 1269-1276, issn 1058-4838, 8 p.Article
Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrumentJORGENSEN, J. H; CRAWFORD, S. A; MCELMEEL, L. M et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 12, pp 5928-5930, issn 0095-1137, 3 p.Article
A Four-Month Gatifloxacin-Containing Regimen for Treating TuberculosisMERLE, Corinne S; FIELDING, Katherine; N'DIAYE, Alimatou et al.The New England journal of medicine. 2014, Vol 371, Num 17, pp 1588-1598, issn 0028-4793, 11 p.Article
Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002MORRISSEY, Ian; BURNETT, Ray; VILJOEN, Louise et al.The Journal of infection. 2004, Vol 49, Num 2, pp 109-114, issn 0163-4453, 6 p.Article
Deux nouvelles quinolones : gatifloxacine et moxifloxacine = New quinolones: gatifloxacine and moxifloxacineBAUMGARTNER, J.-D.Médecine et hygiène. 2001, Vol 59, Num 2350, pp 1334-1337, issn 0025-6749Article
Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogensHERMSEN, Elizabeth D; HOVDE, Laurie B; KONSTANTINIDES, George N et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 4, pp 1633-1635, issn 0066-4804, 3 p.Article
Synthesis and in-vitro cytotoxicity evaluation of Gatifloxacin Mannich basesYOGEESWARI, Perumal; SRIRAM, Dharmarajan; KAVYA, Ramkumar et al.Biomedicine & pharmacotherapy. 2005, Vol 59, Num 9, pp 501-510, issn 0753-3322, 10 p.Article
Pharmacokinetics of gatifloxacin in infants and childrenCAPPARELLI, Edmund V; REED, Michael D; BRADLEY, John S et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 3, pp 1106-1112, issn 0066-4804, 7 p.Article
Evaluation of Initial and Steady-State Gatifloxacin Pharmacokinetics and Dose in Pulmonary Tuberculosis Patients by Using Monte Carlo SimulationsSMYTHE, Wynand; MERLE, Corinne S; MCILLERON, Helen et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4164-4171, issn 0066-4804, 8 p.Article
Loading behavior of gatifloxacin in urine and lake water on a novel magnetic molecularly imprinted polymer used as extraction sorbent with spectrophotometric analysisDRAMOU, Pierre; DELI XIAO; HUA HE et al.Journal of separation science (Print). 2013, Vol 36, Num 5, pp 898-906, issn 1615-9306, 9 p.Article
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South IndiaREDDY, A. K; GARG, P; ALAM, M. R et al.Eye (London. 1987). 2010, Vol 24, Num 1, pp 170-174, issn 0950-222X, 5 p.Article
Interaction of gatifloxacin with efflux transporters: A possible mechanism for drug resistanceKWATRA, Deep; VADLAPATLA, Ramya Krishna; VADLAPUDI, Aswani Dutt et al.International journal of pharmaceutics (Print). 2010, Vol 395, Num 1-2, pp 114-121, issn 0378-5173, 8 p.Article
Square pyramidal copper(II) complexes with forth generation fluoroquinolone and neutral bidentate ligand: Structure, antibacterial, SOD mimic and DNA-interaction studiesPATEL, Mohan N; PARMAR, Pradhuman A; GANDHI, Deepen S et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 3, pp 1227-1235, issn 0968-0896, 9 p.Article
The co-luminescence effect of a europium (III)-lanthanum (III)-gatifloxacin- sodium dodecylbenzene sulfonate system and its application for the determination of trace amount of europium (III)CHANGCHUAN GUO; AIDONG LANG; LEIWANG et al.Journal of luminescence. 2010, Vol 130, Num 4, pp 591-597, issn 0022-2313, 7 p.Article
A Prospective Randomized Evaluation of Topical Gatifloxacin on Conjunctival Flora in Patients Undergoing Intravitreal InjectionsMOSS, Jason M; SANISLO, Steven R; TA, Christopher N et al.Ophthalmology (Rochester, MN). 2009, Vol 116, Num 8, pp 1498-1501, issn 0161-6420, 4 p.Article
Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissuePERLETTI, G; WAGENLEHNER, F. M. E; NABER, K. G et al.International journal of antimicrobial agents (Print). 2009, Vol 33, Num 3, pp 206-210, issn 0924-8579, 5 p.Article
Les nouveaux antituberculeux : Infectieux = The new antituberculosis drugs : InfectiousMARIGOT-OUTTANDY, D; PERRONNE, C.Réanimation (Paris. 2001). 2009, Vol 18, Num 4, pp 334-342, issn 1624-0693, 9 p.Article
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosisRUSTOMJEE, R; LIENHARDT, C; COLEMAN, D. J et al.International journal of tuberculosis and lung disease. 2008, Vol 12, Num 2, pp 128-138, issn 1027-3719, 11 p.Article
Benzalkonium Chloride Enhances the Antibacterial Efficacy of Gatifloxacin in an Experimental Rabbit Model of Intrastromal KeratitisROMANOWSKI, Eric G; MAH, Francis S; KOWALSKI, Regis P et al.Journal of ocular pharmacology and therapeutics. 2008, Vol 24, Num 4, pp 380-384, issn 1080-7683, 5 p.Article
Comparison of One-Day Versus One-Hour Application of Topical Gatifloxacin in Eliminating Conjunctival Bacterial FloraMOSS, Jason M; NGUYEN, David; LIU, Yueyi I et al.Ophthalmology (Rochester, MN). 2008, Vol 115, Num 11, pp 2013-2016, issn 0161-6420, 4 p.Article
The inhibition of gluconeogenesis by gatifloxacin may contribute to its hypoglycaemic actionDROZAK, Jakub; MIECZNIK, Anna; JARZYNA, Robert et al.European journal of pharmacology. 2008, Vol 594, Num 1-3, pp 39-43, issn 0014-2999, 5 p.Article
Gatifloxacin affects GLUT1 gene expression and disturbs glucose homeostasis in vitroGE, Tian-Fang; LAW, Pui Ying Peggy; HEI YI WONG et al.European journal of pharmacology. 2007, Vol 573, Num 1-3, pp 70-74, issn 0014-2999, 5 p.Article